| Serial Number | 97584013 |
| Word Mark | OVASUITE |
| Filing Date | Thursday, September 8, 2022 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Friday, January 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Providing reagent sample testing and diagnostic services for others for scientific research purposes; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; providing medical and scientific research information; providing medical and scientific research information in the field of cancer detection and clinical trials; providing medical and scientific research information in the field of ovarian cancer detection and clinical trials; providing medical and scientific research information in the field of breast cancer detection and clinical trials; providing medical and scientific research services in the field of biomarker testing and cancer screening; medical and scientific research services in the field of cancer treatment and diagnosis; medical and scientific research services in the field of ovarian cancer treatment and diagnosis; medical and scientific research services in the field of breast treatment and diagnosis; medical and scientific research services in the field of cancer treatment and diagnosis; medical and scientific research services in the fields of women's health, genetics, gynecology and cancer; scientific research consulting in the field of genetics; product development in the fields of women's health, genetics, gynecology, diagnostics and cancer; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; consulting services in the fields of laboratory testing and diagnostics; providing a web hosting platform for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; platform as a service (PAAS) featuring computer software platforms for diagnostic testing in the field of women's health; software as a service (SAAS) services featuring software for diagnostic testing; software as a service (SAAS) services featuring software for cancer diagnostic testing; software as a service (SAAS) services featuring software for genetic testing; software as a service (SAAS) services featuring software using artificial intelligence for medical diagnostic testing; providing on-line non-downloadable software using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; providing temporary use of on-line non-downloadable software and applications using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; providing a website featuring non-downloadable software using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 26, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Aspira Women's Health Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Austin, TX 78738 |
| Event Date | Event Description |
| Friday, January 19, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, January 19, 2024 | LETTER OF SUSPENSION E-MAILED |
| Friday, January 19, 2024 | SUSPENSION LETTER WRITTEN |
| Friday, December 22, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 21, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 21, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, September 19, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, September 19, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Saturday, June 24, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, June 24, 2023 | NON-FINAL ACTION E-MAILED |
| Saturday, June 24, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, June 22, 2023 | ASSIGNED TO EXAMINER |
| Monday, September 26, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, September 12, 2022 | NEW APPLICATION ENTERED |